shortagewatch

Home / Levodopa, Decarboxylase Inhibitor and COMT Inhibitor / Sweden

SE ATC N04BA03 · updated 2 Nov 2026

Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Sweden

Is there a Levodopa, Decarboxylase Inhibitor and COMT Inhibitor shortage in Sweden?

Yes. As of 2 Nov 2026, 9 Levodopa, Decarboxylase Inhibitor and COMT Inhibitor products are reported short in Sweden, the first since 15 May 2023. The company estimate for the return is 1 Apr 2027 (latest 1 Oct 2027). Main reason: not stated.

Also short in Italy, Spain, Czechia. All countries.

Affected products in Sweden

CountryProductCompanySinceExpected backReason
SELevodopa/Carbidopa/Entacapone Holsten 150 mg/37,5 mg/200 mg Burk, 100 tabletterHolsten Pharma GmbH15 May 20231 Oct 2027Not stated
SELevodopa/Carbidopa/Entacapone Holsten 150 mg/37,5 mg/200 mg Burk, 130 tabletterHolsten Pharma GmbH15 May 20231 Oct 2027Not stated
SELevodopa/Carbidopa/Entacapone Holsten 200 mg/50 mg/200 mg Burk, 100 tabletterHolsten Pharma GmbH15 May 20231 Oct 2027Not stated
SELevodopa/Carbidopa/Entacapone Holsten 50 mg/12,5 mg/200 mg Burk, 100 tabletterHolsten Pharma GmbH15 May 20231 Oct 2027Not stated
SELevodopa/Carbidopa/Entacapone Holsten 100 mg/25 mg/200 mg Burk, 100 tabletterHolsten Pharma GmbH1 Sep 20251 Oct 2027Not stated
SELevodopa/Carbidopa/Entacapone Holsten 100 mg/25 mg/200 mg Burk, 130 tabletterHolsten Pharma GmbH1 Sep 20251 Oct 2027Not stated
SELevodopa/Carbidopa/Entacapone Holsten 125 mg/31,25 mg/200 mg Burk, 100 tabletterHolsten Pharma GmbH1 Sep 20251 Oct 2027Not stated
SELevodopa/Carbidopa/Entacapone Holsten 75 mg/18,75 mg/200 mg Burk, 100 tabletterHolsten Pharma GmbH1 Sep 20251 Oct 2027Not stated
SEStalevo 125 mg/31,25 mg/ 200 mg Burk, 100 tabletter (PD: 2care4 ApS)Orion Corporation14 Oct 20261 Apr 2027Not stated

Source

Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.